Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Trial of Transfusion of COVID-19 Convalescent Plasma (CCP) to Patients With Moderate to Severe COVID-19

NCT04412486 is registered in ClinicalTrials.gov with Gailen D. Marshall Jr., MD PhD as lead sponsor.

NCT NCT04412486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04412486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Trial of Transfusion of COVID-19 Convalescent Plasma (CCP) to Patients With Moderate to Severe COVID-19
Lead sponsor
Gailen D. Marshall Jr., MD PhD
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2020
Completion date
March 23, 2023
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19